glp 1 and multiple sclerosis You might know them as Ozempic, Wegovy, Mounjaro, Zepbound. GLP-1 receptor agonists are best known for managing diabetes and promoting weight loss, but researchers are discovering a wide spectrum of effective Neuroprotective effects of GLP-1 receptor

[Google Scholar] 86.Speakman JR, de Jong JMA, Sinha S, et al

As with other GLP-1 receptor agonists, such as Ozempic and Wegovy, discontinuing Mounjaro treatment may result in weight regain

These metabolic differences are generally modest compared to the dramatic difference in total weight loss

Although AOM options have been limited for the pediatric population (11), glucagon-like peptide 1 (GLP-1) receptor agonists (GLP-1RA) show significant beneficial effects on both BMI and metabolic health for the treatment of obesity in adults as well as in children and adolescents (4, 12, 13)

It is also not approved for individuals with type 1 diabetes.7 Liraglutide (Saxenda, Victoza) Liraglutide is a once daily injectable GLP-1 RA that can be prescribed for both glycemic control in T2DM and chronic weight management

That is also completely normal